MedPath

Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the esophageal cancer patient

Phase 2
Recruiting
Conditions
esophageal cancer
Registration Number
JPRN-UMIN000008997
Lead Sponsor
Osaka University,Graduate School of Medicine, Department of Gastroenterological Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Synchronous or metachronous (within 5 years) malignancies

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath